Sagility India Limited IPO Overview
Company Overview:
Sagility India Limited, previously known as Berkmeer India Private Limited, specializes in providing healthcare-focused solutions and services. The company serves two primary customer segments in the U.S. healthcare market:
Payers: These include U.S. health insurers who fund and reimburse healthcare services. Sagility supports their entire operational spectrum, offering centralized claims administration, payment integrity, and clinical management services.
Providers: Comprising hospitals, physicians, diagnostics, and medical technology companies, Sagility offers revenue cycle management services to help providers manage billing and treatment claims from payers.
Service Spectrum
Payers: The company’s services to payers include claims administration, payment integrity, and clinical management. Pharmacy Benefit Managers (PBMs), who manage prescription drug coverage for insured members, also benefit from some of these services.
Providers: Revenue cycle management services assist healthcare providers in managing billing, claims, and payment processes efficiently.
Client Base and Growth
US-Based Clients: Sagility exclusively serves U.S.-based clients, with five of the ten largest U.S. payers among their customers as of January 2024.
Longevity: The company’s top five customer groups have an average tenure of 17 years, reflecting a longstanding relationship.
New Customers: Sagility gained 20 new customers in FY 2024 and FY 2023 combined, demonstrating steady growth.
Sagility India Limited: Key IPO Details
IPO Dates: 5 to 7 November, 2024
Price Band: ₹28 to ₹30 per share
Lot Size: 500 shares
Total Issue Size: ₹2,106.60 crores
Retail Quota: 10%
Listing Date: 12th Nov 2024
GMP: Nil (as of now, for informational purposes only)
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matters published here are purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor before making any actual investment decisions, based on the information published here. Any reader making decisions based on any information published here does so entirely at their own risk. Investors should bear in mind that any investment in the stock market is subject to unpredictable market-related risks. The author has no plans to invest in this offer and also the author does not recommend investing in any offer published on this website.